1. Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents
   Jose Luis Daniotti et al, 2016, Front. Oncol. CrossRef
2. Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC).
   Andreas Saltos et al, 2020, Front Oncol CrossRef
3. The Extracellular Matrix and Neuroblastoma Cell Communication—A Complex Interplay and Its Therapeutic Implications
   Irena Horwacik, 2022, Cells CrossRef
4. Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
   Ana María Hernández et al, 2008 CrossRef
5. An Anti-Idiotype Vaccine Elicits a Specific Response to N-Glycolyl Sialic Acid Residues of Glycoconjugates in Melanoma Patients
   Mauro Alfonso et al, 2002 CrossRef
6. Immunotherapy of Neuroblastoma Targeting GD2 and Beyond
   Jung-Tung Hung et al, 2023 CrossRef
7. Inmunoterapia con Racotumomab
   María Inés Penna et al, 2013, RevOnco CrossRef